Exercise after influenza or COVID-19 vaccination increases serum antibody without an increase in side effects

Brain Behav Immun. 2022 May:102:1-10. doi: 10.1016/j.bbi.2022.02.005. Epub 2022 Feb 5.

Abstract

Vaccination is an effective public health measure, yet vaccine efficacy varies across different populations. Adjuvants improve vaccine efficacy but often increase reactogenicity. An unconventional behavioral "adjuvant" is physical exercise at the time of vaccination. Here, in separate experiments, we examined the effect of 90-minute light- to moderate-intensity cycle ergometer or outdoor walk/jog aerobic exercise performed once after immunization on serum antibody response to three different vaccines (2009 pandemic influenza H1N1, seasonal influenza, and COVID-19). Exercise took place after influenza vaccination or after the first dose of Pfizer-BioNTech COVID-19 vaccine. A mouse model of influenza A immunization was used to examine the effect of exercise on antibody response and the role of IFNα as a potential mechanism by treating mice with anti-IFNα antibody. The results show that 90 min of exercise consistently increased serum antibody to each vaccine four weeks post-immunization, and IFNα may partially contribute to the exercise-related benefit. Exercise did not increase side effects after the COVID-19 vaccination. These findings suggest that adults who exercise regularly may increase antibody response to influenza or COVID-19 vaccine by performing a single session of light- to moderate-intensity exercise post-immunization.

Keywords: COVID-19; Exercise; Influenza; Vaccine.

MeSH terms

  • Adjuvants, Immunologic
  • Animals
  • Antibodies
  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza Vaccines*
  • Influenza, Human* / prevention & control
  • Mice
  • Vaccination / methods

Substances

  • Adjuvants, Immunologic
  • Antibodies
  • Antibodies, Viral
  • COVID-19 Vaccines
  • Influenza Vaccines
  • BNT162 Vaccine